ESC 365 - Percutaneous coronary intervention versus medical therapy for coronary lesions with positive fractional flow reserve (FFR) but preserved coronary flow reserve (CFR). A substudy of the COMPARE-ACUTE

ESC Premium Access

Percutaneous coronary intervention versus medical therapy for coronary lesions with positive fractional flow reserve (FFR) but preserved coronary flow reserve (CFR). A substudy of the COMPARE-ACUTE

Session: Assessment of residual risk after percutaneous coronary intervention

Topic: Coronary Circulation, Flow, and Flow Reserve

Speaker: Doctor J. Haeck (Leeuwarden, NL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Joost Haeck

Medical Center Leeuwarden, Leeuwarden (Netherlands (The))

0 follower

4 more presentations in this session

Prognostic impact of sarcopenia on major adverse cardiovascular outcomes in coronary artery disease patients undergoing successful percutaneous coronary intervention

Speaker: Doctor D. Kang (Seoul, KR)

Validation of quantitative flow reserve and residual quantitative flow reserve to predict fractional flow reserve post stenting from the DOCTORS study population

Speaker: Doctor J. Adjedj (Saint Laurent du Var, FR)

Diagnostic performance of quantitative flow ratio from coronary angiography versus fractional flow reserve from computed tomography

Speaker: Doctor H. Emori (Wakayama, JP)

Long-term risk stratification of patients undergoing coronary angiography according to the TIMI risk score for secondary prevention

Speaker: Doctor B. Zafrir (Haifa, IL)

Access the full session

Assessment of residual risk after percutaneous coronary intervention

Speakers: Doctor J. Haeck, Doctor D. Kang, Doctor J. Adjedj, Doctor H. Emori, Doctor B. Zafrir

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources